Novartis CEO Touts R&D 'Wild Cards' As Proof Of Deep Pipeline

Multi-Billion Dollar Opportunities In Development

 
• By Kevin Grogan
poker
Novartis reveals strong hand in R&D • Source: Shutterstock

More from Clinical Trials

More from R&D